Show items per page
Elements: 6
Page 1 on 1
 TitleAuthors / EditorsDate
add to browser selection
Amygdalar nuclei and hippocampal subfields on MRI: Test-retest reliability of automated volumetry across different MRI sites and vendors Quattrini, Giulia; Pievani, Michela; Jovicich, Jorge; Aiello, Marco; ... Marizzoni, Moira 2020
add to browser selection
Incremental value of amyloid-PET versus CSF in the diagnosis of Alzheimer’s disease Ramusino, Matteo Cotta; Garibotto, Valentina; Bacchin, Ruggero; Altomare, Daniele; ... Frisoni, Giovanni 2020
add to browser selection
Clinical validity of brain fluorodeoxyglucose positron emission tomography as a biomarker for Alzheimer's disease in the context of a structured 5-phase development framework Garibotto, Valentina; Herholz, Karl; Boccardi, Marina; Picco, Agnese; ... Ratib, Osman 2017
add to browser selection
Clinical validity of increased cortical uptake of amyloid ligands on PET as a biomarker for Alzheimer's disease in the context of a structured 5-phase development framework Chiotis, Konstantinos; Saint-Aubert, Laure; Boccardi, Marina; Gietl, Anton; ... Nordberg, Agneta 2017
add to browser selection
Clinical validity of presynaptic dopaminergic imaging with 123I-ioflupane and noradrenergic imaging with 123I-MIBG Sonni, Ida; Ratib, Osman; Boccardi, Marina; Picco, Agnese; ... Varrone, Andrea 2017
add to browser selection
Visual Versus Semi-Quantitative Analysis of 18F-FDG-PET in Amnestic MCI: An European Alzheimer's Disease Consortium (EADC) Project Morbelli, Silvia; Brugnolo, Andrea; Bossert, Irene; Buschiazzo, Ambra; ... Frisoni, Giovanni 2015